 | • レポートコード：QYR2104Z1242 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、脳血管障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（頸動脈内膜剥離術、頸動脈血管形成術/頸動脈ステント留置術、薬物療法（アスピリン、チクロピジン・スルフィンピラゾン））、用途別市場規模（学術・研究機関、製薬・バイオテクノロジー企業、病院・診断センター、委託研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・脳血管障害の市場動向 ・企業の競争状況、市場シェア ・脳血管障害の種類別市場規模（頸動脈内膜剥離術、頸動脈血管形成術/頸動脈ステント留置術、薬物療法（アスピリン、チクロピジン・スルフィンピラゾン）） ・脳血管障害の用途別市場規模（学術・研究機関、製薬・バイオテクノロジー企業、病院・診断センター、委託研究機関、その他） ・脳血管障害の北米市場規模2016-2027（アメリカ、カナダ） ・脳血管障害のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・脳血管障害のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・脳血管障害の中南米市場規模2016-2027（メキシコ、ブラジル） ・脳血管障害の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、Amgen、GlaxoSmithKline、Sanofi-Aventis、Merck、Sangamo BioSciences、Aldagen） ・結論 |
Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
Market Analysis and Insights: Global Cerebrovascular Disease Market
The global Cerebrovascular Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cerebrovascular Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cerebrovascular Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cerebrovascular Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cerebrovascular Disease market.
Global Cerebrovascular Disease Scope and Market Size
Cerebrovascular Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cerebrovascular Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Carotid Endarterectomy
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Segment by Application
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
Amgen
GlaxoSmithKline
Sanofi-Aventis
Merck
Sangamo BioSciences
Aldagen
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Carotid Endarterectomy
1.2.3 Carotid Angioplasty Or Carotid Artery Stenting
1.2.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
1.3 Market by Application
1.3.1 Global Cerebrovascular Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cerebrovascular Disease Market Perspective (2016-2027)
2.2 Cerebrovascular Disease Growth Trends by Regions
2.2.1 Cerebrovascular Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cerebrovascular Disease Historic Market Share by Regions (2016-2021)
2.2.3 Cerebrovascular Disease Forecasted Market Size by Regions (2022-2027)
2.3 Cerebrovascular Disease Industry Dynamic
2.3.1 Cerebrovascular Disease Market Trends
2.3.2 Cerebrovascular Disease Market Drivers
2.3.3 Cerebrovascular Disease Market Challenges
2.3.4 Cerebrovascular Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cerebrovascular Disease Players by Revenue
3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2016-2021)
3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2016-2021)
3.2 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cerebrovascular Disease Revenue
3.4 Global Cerebrovascular Disease Market Concentration Ratio
3.4.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2020
3.5 Cerebrovascular Disease Key Players Head office and Area Served
3.6 Key Players Cerebrovascular Disease Product Solution and Service
3.7 Date of Enter into Cerebrovascular Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cerebrovascular Disease Breakdown Data by Type
4.1 Global Cerebrovascular Disease Historic Market Size by Type (2016-2021)
4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2022-2027)
5 Cerebrovascular Disease Breakdown Data by Application
5.1 Global Cerebrovascular Disease Historic Market Size by Application (2016-2021)
5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cerebrovascular Disease Market Size (2016-2027)
6.2 North America Cerebrovascular Disease Market Size by Type
6.2.1 North America Cerebrovascular Disease Market Size by Type (2016-2021)
6.2.2 North America Cerebrovascular Disease Market Size by Type (2022-2027)
6.2.3 North America Cerebrovascular Disease Market Size by Type (2016-2027)
6.3 North America Cerebrovascular Disease Market Size by Application
6.3.1 North America Cerebrovascular Disease Market Size by Application (2016-2021)
6.3.2 North America Cerebrovascular Disease Market Size by Application (2022-2027)
6.3.3 North America Cerebrovascular Disease Market Size by Application (2016-2027)
6.4 North America Cerebrovascular Disease Market Size by Country
6.4.1 North America Cerebrovascular Disease Market Size by Country (2016-2021)
6.4.2 North America Cerebrovascular Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cerebrovascular Disease Market Size (2016-2027)
7.2 Europe Cerebrovascular Disease Market Size by Type
7.2.1 Europe Cerebrovascular Disease Market Size by Type (2016-2021)
7.2.2 Europe Cerebrovascular Disease Market Size by Type (2022-2027)
7.2.3 Europe Cerebrovascular Disease Market Size by Type (2016-2027)
7.3 Europe Cerebrovascular Disease Market Size by Application
7.3.1 Europe Cerebrovascular Disease Market Size by Application (2016-2021)
7.3.2 Europe Cerebrovascular Disease Market Size by Application (2022-2027)
7.3.3 Europe Cerebrovascular Disease Market Size by Application (2016-2027)
7.4 Europe Cerebrovascular Disease Market Size by Country
7.4.1 Europe Cerebrovascular Disease Market Size by Country (2016-2021)
7.4.2 Europe Cerebrovascular Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cerebrovascular Disease Market Size (2016-2027)
8.2 Asia-Pacific Cerebrovascular Disease Market Size by Type
8.2.1 Asia-Pacific Cerebrovascular Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cerebrovascular Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cerebrovascular Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Cerebrovascular Disease Market Size by Application
8.3.1 Asia-Pacific Cerebrovascular Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cerebrovascular Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cerebrovascular Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Cerebrovascular Disease Market Size by Region
8.4.1 Asia-Pacific Cerebrovascular Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cerebrovascular Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cerebrovascular Disease Market Size (2016-2027)
9.2 Latin America Cerebrovascular Disease Market Size by Type
9.2.1 Latin America Cerebrovascular Disease Market Size by Type (2016-2021)
9.2.2 Latin America Cerebrovascular Disease Market Size by Type (2022-2027)
9.2.3 Latin America Cerebrovascular Disease Market Size by Type (2016-2027)
9.3 Latin America Cerebrovascular Disease Market Size by Application
9.3.1 Latin America Cerebrovascular Disease Market Size by Application (2016-2021)
9.3.2 Latin America Cerebrovascular Disease Market Size by Application (2022-2027)
9.3.3 Latin America Cerebrovascular Disease Market Size by Application (2016-2027)
9.4 Latin America Cerebrovascular Disease Market Size by Country
9.4.1 Latin America Cerebrovascular Disease Market Size by Country (2016-2021)
9.4.2 Latin America Cerebrovascular Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cerebrovascular Disease Market Size (2016-2027)
10.2 Middle East & Africa Cerebrovascular Disease Market Size by Type
10.2.1 Middle East & Africa Cerebrovascular Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cerebrovascular Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cerebrovascular Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Cerebrovascular Disease Market Size by Application
10.3.1 Middle East & Africa Cerebrovascular Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cerebrovascular Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cerebrovascular Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Cerebrovascular Disease Market Size by Country
10.4.1 Middle East & Africa Cerebrovascular Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cerebrovascular Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
11.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Cerebrovascular Disease Introduction
11.2.4 Amgen Revenue in Cerebrovascular Disease Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
11.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Details
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
11.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2016-2021)
11.4.5 Sanofi-Aventis Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Cerebrovascular Disease Introduction
11.5.4 Merck Revenue in Cerebrovascular Disease Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Sangamo BioSciences
11.6.1 Sangamo BioSciences Company Details
11.6.2 Sangamo BioSciences Business Overview
11.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
11.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2016-2021)
11.6.5 Sangamo BioSciences Recent Development
11.7 Aldagen
11.7.1 Aldagen Company Details
11.7.2 Aldagen Business Overview
11.7.3 Aldagen Cerebrovascular Disease Introduction
11.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2016-2021)
11.7.5 Aldagen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cerebrovascular Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Carotid Endarterectomy
Table 3. Key Players of Carotid Angioplasty Or Carotid Artery Stenting
Table 4. Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Table 5. Global Cerebrovascular Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cerebrovascular Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cerebrovascular Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cerebrovascular Disease Market Share by Regions (2016-2021)
Table 9. Global Cerebrovascular Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cerebrovascular Disease Market Share by Regions (2022-2027)
Table 11. Cerebrovascular Disease Market Trends
Table 12. Cerebrovascular Disease Market Drivers
Table 13. Cerebrovascular Disease Market Challenges
Table 14. Cerebrovascular Disease Market Restraints
Table 15. Global Cerebrovascular Disease Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cerebrovascular Disease Market Share by Players (2016-2021)
Table 17. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebrovascular Disease as of 2020)
Table 18. Ranking of Global Top Cerebrovascular Disease Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cerebrovascular Disease Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cerebrovascular Disease Product Solution and Service
Table 22. Date of Enter into Cerebrovascular Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cerebrovascular Disease Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cerebrovascular Disease Revenue Market Share by Type (2016-2021)
Table 26. Global Cerebrovascular Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cerebrovascular Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cerebrovascular Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cerebrovascular Disease Revenue Market Share by Application (2016-2021)
Table 30. Global Cerebrovascular Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cerebrovascular Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cerebrovascular Disease Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cerebrovascular Disease Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cerebrovascular Disease Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cerebrovascular Disease Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cerebrovascular Disease Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cerebrovascular Disease Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cerebrovascular Disease Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cerebrovascular Disease Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cerebrovascular Disease Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cerebrovascular Disease Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cerebrovascular Disease Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cerebrovascular Disease Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cerebrovascular Disease Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cerebrovascular Disease Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cerebrovascular Disease Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cerebrovascular Disease Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cerebrovascular Disease Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cerebrovascular Disease Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cerebrovascular Disease Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cerebrovascular Disease Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cerebrovascular Disease Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cerebrovascular Disease Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cerebrovascular Disease Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cerebrovascular Disease Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cerebrovascular Disease Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cerebrovascular Disease Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cerebrovascular Disease Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cerebrovascular Disease Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cerebrovascular Disease Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cerebrovascular Disease Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Cerebrovascular Disease Product
Table 65. Johnson & Johnson Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Cerebrovascular Disease Product
Table 70. Amgen Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Cerebrovascular Disease Product
Table 75. GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Sanofi-Aventis Company Details
Table 78. Sanofi-Aventis Business Overview
Table 79. Sanofi-Aventis Cerebrovascular Disease Product
Table 80. Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 81. Sanofi-Aventis Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Cerebrovascular Disease Product
Table 85. Merck Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Sangamo BioSciences Company Details
Table 88. Sangamo BioSciences Business Overview
Table 89. Sangamo BioSciences Cerebrovascular Disease Product
Table 90. Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 91. Sangamo BioSciences Recent Development
Table 92. Aldagen Company Details
Table 93. Aldagen Business Overview
Table 94. Aldagen Cerebrovascular Disease Product
Table 95. Aldagen Revenue in Cerebrovascular Disease Business (2016-2021) & (US$ Million)
Table 96. Aldagen Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cerebrovascular Disease Market Share by Type: 2020 VS 2027
Figure 2. Carotid Endarterectomy Features
Figure 3. Carotid Angioplasty Or Carotid Artery Stenting Features
Figure 4. Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Features
Figure 5. Global Cerebrovascular Disease Market Share by Application: 2020 VS 2027
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
Figure 8. Hospitals & Diagnostic Centers Case Studies
Figure 9. Contract Research Organizations Case Studies
Figure 10. Others Case Studies
Figure 11. Cerebrovascular Disease Report Years Considered
Figure 12. Global Cerebrovascular Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Cerebrovascular Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Cerebrovascular Disease Market Share by Regions: 2020 VS 2027
Figure 15. Global Cerebrovascular Disease Market Share by Regions (2022-2027)
Figure 16. Global Cerebrovascular Disease Market Share by Players in 2020
Figure 17. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cerebrovascular Disease as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2020
Figure 19. Global Cerebrovascular Disease Revenue Market Share by Type (2016-2021)
Figure 20. Global Cerebrovascular Disease Revenue Market Share by Type (2022-2027)
Figure 21. North America Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Cerebrovascular Disease Market Share by Type (2016-2027)
Figure 23. North America Cerebrovascular Disease Market Share by Application (2016-2027)
Figure 24. North America Cerebrovascular Disease Market Share by Country (2016-2027)
Figure 25. United States Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Cerebrovascular Disease Market Share by Type (2016-2027)
Figure 29. Europe Cerebrovascular Disease Market Share by Application (2016-2027)
Figure 30. Europe Cerebrovascular Disease Market Share by Country (2016-2027)
Figure 31. Germany Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Cerebrovascular Disease Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Cerebrovascular Disease Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Cerebrovascular Disease Market Share by Region (2016-2027)
Figure 41. China Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Cerebrovascular Disease Market Share by Type (2016-2027)
Figure 49. Latin America Cerebrovascular Disease Market Share by Application (2016-2027)
Figure 50. Latin America Cerebrovascular Disease Market Share by Country (2016-2027)
Figure 51. Mexico Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Cerebrovascular Disease Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Cerebrovascular Disease Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Cerebrovascular Disease Market Share by Country (2016-2027)
Figure 57. Turkey Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Cerebrovascular Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 63. Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 65. Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 66. Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の頸動脈狭窄症治療薬市場 2021：企業別、地域別、種類・用途別 The Carotid Ttenosis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界の頸動脈ステント市場 2021：企業別、地域別、種類・用途別 The Carotid Stent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界の冠動脈疾患治療市場規模・現状・予測（2021年-2027年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…
- 世界の冠動脈疾患治療市場規模・現状・予測（2021年-2027年） Coronary artery disease (CAD), also known as ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. Our research analysis on the global coronary artery disease therapeutics market has identified that…
- 世界のメニエール病治療薬市場規模・現状・予測（2021年-2027年） Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…